The prognostic relevance of estimates of proliferative activity in early breast cancer.
Heatley
M K
MK
Maxwell
P
P
Whiteside
C
C
Ewing
P
P
Toner
P G
PG
D000911:Antibodies, Monoclonal / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000401:mortality* / Q000473:pathology / Q000503:physiopathology*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000378:metabolism / Q000401:mortality* / Q000473:pathology / Q000503:physiopathology*; D049109:Cell Proliferation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis; D008198:Lymph Nodes / Q000473:pathology; D008940:Mitotic Index; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011379:Prognosis; D011960:Receptors, Estrogen / Q000378:metabolism; D015996:Survival Rate; D013997:Time Factors
D000911:Antibodies, Monoclonal; D019394:Ki-67 Antigen; D011960:Receptors, Estrogen